• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Developmental or intellectual disabilities may be associated with increased risk of long COVID

byRhianna DavisandAlex Chan
December 28, 2023
in Chronic Disease, Infectious Disease, Neurology, Pediatrics
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. Individuals with an intellectual or developmental disability were more likely to experience negative outcomes 80-190 days after COVID-19 infection.

Evidence Rating Level: 2 (Good)

Early in the COVID-19 pandemic, researchers determined that individuals with intellectual and developmental disabilities (IDD) were more likely to contract severe COVID-19 disease. To date, no studies have investigated the long-term effects of COVID-19 infection in this population. In this study, 36,308 participants both with and without IDD were identified from the TriNetX network, which includes subjects from Brazil, Taiwan, the United States, and Poland. Follow-up occurred over the first 90 to 180 days after COVID-19 infection. During this period, those with an IDD were more likely to develop post-COVID-19 conditions compared to those without an IDD (hazard ratio [HR], 1.120; 95% confidence interval [CI]: 1.053-1.191). These conditions included abnormal breathing, cough, fatigue, cognitive symptoms, myalgia, disordered sleep, and abdominal symptoms. A limitation of this study is that many participants with an IDD have difficulty explaining their symptoms, which may lead to underdetection or inaccurate diagnosis of post-COVID-19 syndromes. This study demonstrates that individuals with an IDD are more likely to experience negative outcomes 80-190 days after being infected with COVID-19. This vulnerable population may need more monitoring in clinical settings following COVID-19 infection. 

Click to read the study in BMC Medicine

Image: PD

©2023 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

RELATED REPORTS

Delayed initiation of antibiotic therapy is associated with worse outcomes in skin and soft tissue infections

Adjuvanted influenza vaccines and high-dose influenza vaccines may have similar effectiveness in adult patients

Maternal use of benzodiazepines and non-benzodiazepine hypnotics is not associated with increased risk of psychiatric

Tags: COVID-19developmental disabilityinfectious diseaseintellectual disabilitypediatrics
Previous Post

The 2 Minute Medicine Podcast Episode 31

Next Post

Mindfulness therapy improves mental health scores in university students

RelatedReports

Transthoracic echocardiography can rule out endocarditis in low-risk bacteremic patients
Infectious Disease

Delayed initiation of antibiotic therapy is associated with worse outcomes in skin and soft tissue infections

May 22, 2026
Live attenuated vaccine less effective in recent influenza season
Emergency

Adjuvanted influenza vaccines and high-dose influenza vaccines may have similar effectiveness in adult patients

May 15, 2026
Prenatal antidepressant exposure may increase risk of poor motor development
Chronic Disease

Maternal use of benzodiazepines and non-benzodiazepine hypnotics is not associated with increased risk of psychiatric

May 6, 2026
Novel coronavirus identified from patients with pneumonia in Wuhan, China
Cardiology

COVID-19 vaccination is associated with reduced risk of new-onset atrial fibrillation following COVID-19 infection

April 29, 2026
Next Post
High incidence of cognitive impairment associated with colorectal cancer

Mindfulness therapy improves mental health scores in university students

#VisualAbstract: Mirvetuximab soravtansine-gynx compared to chemotherapy in folate receptor alpha-positive platinum resistant ovarian cancer led to improved survival

#VisualAbstract: Atezolizumab Monotherapy vs Chemotherapy In Advanced Urothelial Carcinoma

#VisualAbstract: Nirsevimab prevents hospitalizations due to respiratory syncytial virus (RSV) in infants compared to standard care

#VisualAbstract: Nirsevimab prevents hospitalizations due to respiratory syncytial virus (RSV) in infants compared to standard care

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Food and Drug Administration reviews model for predicting drug related liver injury
  • Recombinant Zoster Vaccination May Reduce Dementia Risk in Older Adults
  • Multimodal prehabilitation improves postoperative outcomes after spinal fusion surgery 
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.